A Targeted Therapy for Protein and Lipid Kinases in Chronic Lymphocytic Leukemia

E-ISSN： 1875-533x|19|31|5294-5318

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.31, 2012-11, pp. : 5294-5318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia

By Balakrishnan Kumudha Gandhi Varsha

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 4, 2012-04 ,pp. : 409-423

Informa Healthcare

Access to resources Recommend Favorite

Chronic Lymphocytic Leukemia Therapy: Beyond Chemoimmunotherapy

Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. : 3356-3362

Bentham Science Publishers

Access to resources Recommend Favorite

Therapy of Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia

Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. : 3399-3405

Bentham Science Publishers

Access to resources Recommend Favorite

Genetics, Gene Expression, and Targeted Therapies in Chronic Lymphocytic Leukemia

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1313-1327

Bentham Science Publishers

Access to resources Recommend Favorite

Pentostatin in chronic lymphocytic leukemia

By Sauter Craig Lamanna Nicole Weiss Mark A

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1217-1222

Informa Healthcare

Access to resources Recommend Favorite